View Item 

Show simple item record

Utilizing public health data to geotarget hepatitis C virus elimination approaches in urban and rural Michigan
dc.contributor.authorWeinheimer‐haus, Eileen M.
dc.contributor.authorYu, Xianshi
dc.contributor.authorSingal, Amit G.
dc.contributor.authorNaylor, Keith B.
dc.contributor.authorAmmori, Candice
dc.contributor.authorCoyle, Joseph
dc.contributor.authorNallamothu, Brahmajee K.
dc.contributor.authorWitala, Wyndy
dc.contributor.authorZhu, Ji
dc.contributor.authorWaljee, Akbar K.
dc.date.accessioned2021-02-04T21:54:45Z
dc.date.available2022-03-04 16:54:42en
dc.date.available2021-02-04T21:54:45Z
dc.date.issued2021-02
dc.identifier.citationWeinheimer‐haus, Eileen M. ; Yu, Xianshi; Singal, Amit G.; Naylor, Keith B.; Ammori, Candice; Coyle, Joseph; Nallamothu, Brahmajee K.; Witala, Wyndy; Zhu, Ji; Waljee, Akbar K. (2021). "Utilizing public health data to geotarget hepatitis C virus elimination approaches in urban and rural Michigan." Journal of Viral Hepatitis (2): 440-444.
dc.identifier.issn1352-0504
dc.identifier.issn1365-2893
dc.identifier.urihttps://hdl.handle.net/2027.42/166278
dc.description.abstractUsing Michigan public health data, we assessed geographical access to specialist providers for hepatitis C virus (HCV) treatment in urban and rural areas in Michigan and explored correlates of HCV in these areas to help inform HCV elimination planning and resource allocations. We found higher HCV incidence in urban areas, lower treatment specialist access in rural areas, but few correlates of HCV across adult populations in both areas. State and local HCV elimination planning should include population- based screening among all adults and address geographical barriers to care.
dc.publisherWiley Periodicals, Inc.
dc.subject.otherhepatitis C elimination
dc.subject.othertreatment access
dc.subject.otherrurality
dc.subject.otherhepatitis C policy
dc.titleUtilizing public health data to geotarget hepatitis C virus elimination approaches in urban and rural Michigan
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/166278/1/jvh13438.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/166278/2/jvh13438_am.pdf
dc.identifier.doi10.1111/jvh.13438
dc.identifier.doihttps://dx.doi.org/10.7302/201
dc.identifier.sourceJournal of Viral Hepatitis
dc.identifier.citedreferenceRyerson AB, Schillie S, Barker LK, Kupronis BA, Wester C. Vital signs: newly reported acute and chronic hepatitis C cases - United States, 2009- 2018. MMWR Morb Mortal Wkly Rep. 2020; 69 ( 14 ): 399 - 404.
dc.identifier.citedreferenceRazavi H, Sanchez Gonzalez Y, Yuen C, Cornberg M. Global timing of hepatitis C virus elimination in high- income countries. Liver Int. 2020; 40 ( 3 ): 522 - 529.
dc.identifier.citedreferenceSchillie S, Wester C, Osborne M, Wesolowski L, Ryerson AB. CDC recommendations for hepatitis C screening among adults - United States, 2020. MMWR Recomm Rep. 2020; 69 ( 2 ): 1 - 17.
dc.identifier.citedreferenceMoore MS, Greene SK, Bocour A, et al. Comprehensive nationwide chronic hepatitis C surveillance is necessary for accurate state- level prevalence estimates. J Viral Hepat. 2019; 26 ( 9 ): 1124 - 1126.
dc.identifier.citedreferenceBull- Otterson L, Huang YA, Zhu W, King H, Edlin BR, Hoover KW. HIV and hepatitis C virus infection testing among commercially insured persons who inject drugs, United States, 2010- 2017. J Infect Dis. 2020; 222 ( 6 ): 940 - 947.
dc.identifier.citedreferenceEckhardt BJ, Scherer M, Winkelstein E, Marks K, Edlin BR. Hepatitis C treatment outcomes for people who inject drugs treated in an accessible care program located at a syringe service program. Open Forum Infect Dis. 2018; 5 ( 4 ): ofy048.
dc.identifier.citedreferenceMichigan Department of Community Health. Michigan Substance Use Disorder Data Repository. available at http://mi-suddr.com
dc.identifier.citedreferenceMichigan Department of Health and Human Services. Hepatitis B and C Annual Surveillance Report. 2017. available at https://www.michigan.gov/documents/mdhhs/VH_Annual_Report_2017_FINAL_630629_7.pdf
dc.working.doi10.7302/201en
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jvh13438.pdf
Size:
508.6KB
Format:
PDF
View/Open
Name:
jvh13438_am.pdf
Size:
214.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.